Funding-Partnerships for Next Generation Biodefense Diagnostics (R01); November 4, 2010

Key Dates
Release/Posted Date:  July 8, 2010
Opening Date:  October 4, 2010 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date: October 4, 2010
NOTE: On-time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization). 
Application Due Date: November 4, 2010
Peer Review Date: March, 2011
Council Review Date May, 2011
Earliest Anticipated Start Date: July, 2011
Additional Information To Be Available Date (Activation Date): Not Applicable.
Expiration Date: November 5, 2010

Executive Summary

• Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), invites applications for early stage product development projects to establish proof-of-concept for potential next generation diagnostics products that do not involve nucleic acid amplification.
• Mechanism of Support. This FOA will utilize the R01 award mechanism.
• Funds Available and Anticipated Number of Awards. The NIAID intends to commit $9 million in total costs in FY2011 to fund 7 to 10 applications in response to this FOA.
• Budget and Project Period. Budgets for direct costs of up to $750,000 per year and a project duration of 5 years may be requested. Applicants requesting budgets in excess of $750,000 in direct costs in any given year must receive approval from the NIAID Program Officer prior to submission.
• Application Research Strategy Length: The R01 Research Strategy section may not exceed 12 pages, including tables, graphs, figures, diagrams, and charts. See http://grants1.nih.gov/grants/funding/funding_program.htm.
• Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply.
• Eligible Project Directors/Principal Investigators (PDs/PIs). Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/ organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
• Number of PDs/PIs. More than one PD/PI (i.e., multiple PDs/PIs) may be designated on the application.
• Number of Applications. Applicants may submit more than one application, provided each application is scientifically distinct.
• Resubmissions.  Resubmission applications are not permitted in response to this FOA.
• Renewals.  Renewal applications are not permitted in response to this FOA.
• Special Date(s). This FOA uses non-standard due dates. See Receipt, Review and Anticipated Start Dates.
• Application Materials. See Section IV.1 for application materials.
• General Information. For general information on SF424 (R&R) Application and Electronic Submission, see these Web sites:
• SF424 (R&R) Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm
• General information on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/
• Hearing Impaired. Telecommunications for the hearing impaired are available at: TTY:  (301) 451-5936

Link to Full Announcement

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-017.html